REGULATION OF LABORATORY DEVELOPED TESTS (LDTs) by the federal Food and Drug Administration (FDA) certainly has the attention of lab executives and pathologists across the nation. As you will read here, since May two different lab industry lawsuits—now consolidated into one case—were filed in a federal court in Texas and each challenges the FDA’s statutory […]
To access this post, you must purchase The Dark Report.